Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine

Brain Research

Volumn 949, Issue 1-2, 2002, Pages 131-138

  Ohashi, Satoshi ^a   Matsumoto, Machiko ^a   Otani, Hiroshi ^a   Mori, Kiyoshi ^a   Togashi, Hiroko ^a   Ueno, Ken ichi ^a   Kaku, Asako ^b   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Fluvoxamine; Hippocampo medial prefrontal cortex pathway; Long term potentiation; Synaptic plasticity

Indexed keywords

FLUVOXAMINE; HALOTHANE; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EVOKED RESPONSE; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NERVE PROJECTION; NERVE STIMULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBICULUM;

AFFERENT PATHWAYS; ANIMALS; ELECTROPHYSIOLOGY; FLUVOXAMINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURONAL PLASTICITY; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0037072545     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02973-6     Document Type: Article

References (47)

1. + current in mammalian neurons. Proc. Natl. Acad. Sci. USA. 92:1995;6635-6639.
2. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15:1993;243-245.
3. Bernabeu R., Bevilaqua L., Ardenghi P., Bromberg E., Schmitz P., Bianchin M., Izquierdo I., Medina J.H. Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats. Proc. Natl. Acad. Sci. USA. 94:1997;7041-7046.
4. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry. 157:2000;115-117.
5. Burette F., Jay T.M., Laroche S. Reversal of LTP in the hippocampal afferent fiber system to the prefrontal cortex in vivo with low-frequency patterns of stimulation that do not produce LTD. J. Neurophysiol. 78:1997;1155-1160.
6. Bymaster F.P., Zhang W., Carter P.A., Shaw J., Chernet E., Phebus L., Wong D.T., Perry K.W. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology. 160:2002;353-361.
7. Condé F., Maire-Lepoivre E., Audinat E., Crépel F. Afferent connections of the medial frontal cortex of the rat. II. Cortical and subcortical afferents. J. Comp. Neurol. 352:1995;567-593.
8. Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA. 98:2001;12796-12801.
9. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Friston K.J., Frackowiak R.S.J. Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J. Neurol. Neurosurg. Psychiatry. 55:1992;768-773.
10. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Frackowiak R.S.J. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol. Med. 24:1994;849-857.
11. Doyère V., Burette F., Negro C.R.-D., Laroche S. Long-term potentiation of hippocampal afferents and efferents to prefrontal cortex: implications for associative learning. Neuropsychologia. 31:1993;1031-1053.
12. Drevets W.C., Price J.L., Simpson J.R. Jr., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
13. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54:1997;597-606.
14. Duman R.S., Malberg J., Thome J. Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry. 46:1999;1181-1191.
15. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry. 48:2000;732-739.
16. 4 receptors. Trends Pharmacol. Sci. 16:1995;391-398.
17. Floresco S.B., Seamans J.K., Phillips A.G. Differential effects of lidocaine infusions into the ventral CA1/subiculum or the nucleus accumbens on the acquisition and retention of spatial information. Behav. Brain Res. 81:1996;163-171.
18. Floresco S.B., Seamans J.K., Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J. Neurosci. 17:1997;1880-1890.
19. Frey U., Huang Y.-Y., Kandel E.R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science. 260:1993;1661-1664.
20. Geretsegger C., Bohmer F., Ludwig M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Int. Clin. Psychopharmacol. 9:1994;25-29.
21. Gould E., Tanapat P., McEwen B.S., Flügge G., Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. USA. 95:1998;3168-3171.
22. Huang Y.-Y., Li X.-C., Kandel E.R. cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell. 79:1994;69-79.
23. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol. 313:1991;574-586.
24. Jay T.M., Gurden H., Yamaguchi T. Rapid increase in PKA activity during long-term potentiation in the hippocampal afferent fibre system to the prefrontal cortex in vivo. Eur. J. Neurosci. 10:1998;3302-3306.
25. Jordan S., Kramer G.L., Zukas P.K., Moeller M., Petty F. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse. 18:1994;294-297.
26. Kennedy S.H., Evans K.R., Krüger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry. 158:2001;899-905.
27. Laroche S., Jay T.M., Thierry A.-M. Long-term potentiation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region. Neurosci. Lett. 114:1990;184-190.
28. Laroche S., Davis S., Jay T.M. Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus. 10:2000;438-446.
29. Levkovits Y., Grisaru N., Segal M. Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology. 25:2001;608-616.
30. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P.V., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1:1998;69-73.
31. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20:2000;9104-9110.
32. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat. Med. 7:2001;541-547.
33. 4 receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J. Pharmacol. Exp. Ther. 296:2001;676-682.
34. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 9:1997;471-481.
35. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry. 156:1999;675-682.
36. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22:1999;105-122.
37. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53:1989;1644-1647.
38. Öngür D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA. 95:1998;13290-13295.
39. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition: 1986;Academic Press, New York.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd Edition: 1997; Academic Press, San Diego.
41. Renard C.E., Fiocco A.J., Clenet F., Hascoet M., Bourin M. Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology. 159:2001;42-50.
42. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA. 93:1996;3908-3913.
43. Stewart C.A., Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology. 148:2000;217-223.
44. Takamori K., Yoshida S., Okuyama S. Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci. 69:2001;1919-1926.
45. Takita M., Izaki Y., Jay T.M., Kaneko H., Suzuki S.S. Induction of stable long-term depression in vivo in the hippocampal-prefrontal cortex pathway. Eur. J. Neurosci. 11:1999;4145-4148.
46. Thierry A.-M., Gioanni Y., Dégénétais E., Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus. 10:2000;411-419.
47. Watanabe Y., Gould E., Daniels D.C., Cameron H., McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur. J. Pharmacol. 222:1992;157-162.